Thank you to everyone who visited our booth and engaged with us at #IDWeek2022 ! To learn more about Novavax, visit our website: novav.ax/3TNShUX

Calling all attendees of IDWeek: visit us at the Novavax Sponsored Learning Lounge to learn more about 'Using Behavioral Science to Help Understand Vaccine Hesitancy.' You won't want to miss out! #IDWeek2022

TODAY: Don't miss our Vice President, Vaccine Clinical Development, Dr. Vivek Shinde's presentation, 'Safety and Immunogenicity of COVID Influenza Combination Vaccine,' from 12:15-1:30pm EST at IDWeek. Will you be there? #IDWeek2022

NEW: Novavax showcased data from expanding vaccine portfolio at IDWeek 2022: ir.novavax.com/2022-10-20-Nov… #IDWeek2022

TUNE IN: Germán Áñez, M.D. will be giving an oral presentation on 'Safety and Immunogenicity of a Booster Dose of Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) in Adults from the PREVENT-19 Trial in the United States' today from 1:57-2:09pm EST. Don't miss this! #IDWeek2022

Novavax is a proud sponsor of IDWeek taking place in Washington, D.C. from October 19 -23! If you are planning to attend, make sure to stop by the Novavax booth to learn more about what it means to #BeNovalutionary . #IDWeek2022

Thank you to everyone who joined us at #WVCEU ! To learn more about Novavax, visit our website: novav.ax/3CvEhIy

Thank you to everyone who attended the 2022 Vaccines Summit! To learn more about Novavax, visit our website: novav.ax/3CAxXiS

TODAY: Make sure to attend Dr. Vivek Shinde's presentation 'Update on Novavax Investigational Influenza vaccine and COVID-19-INFLUENZA Combination Vaccine development' at World Vaccine Congress World Vaccine Congress Europe! You won't want to miss it. #WVCEU

TODAY: Our Executive Director, Clinical Development, Germán Áñez, M.D. , and our Senior Director, Clinical Development, Dr. Chijioke Bennett, will lead a Panel Discussion on 'Paving the way for Protein: Novavax's COVID-19 Vaccine as a Booster and Variant-adapted' at #WVCEU . See you there!

TODAY: Our very own Lisa Dunkle, Vice President of Research, will give a presentation on 'COVID-19 Vaccine Registration Clinical Trials: Building the Plane While Flying' at the 2022 Vaccines Summit. You won't want to miss it!

Novavax is proud to sponsor Vaccines Summit 2022 in Washington, D.C on October 11-13th! Will we see you there?

Novavax is a proud sponsor of the World Vaccine Congress Vaccine Congress Europe! We'll be in Barcelona to partake in discussions alongside leaders in pharma and biotech. Make sure to visit our booth to learn more about Novavax. #WVCEU

NEW: Switzerland's Federal Office of Public Health (BAG – OFSP – UFSP) has recommended our #COVID19Vaccine as a booster in adults aged 18 and older regardless of previous vaccine history. Learn more: novav.ax/3V9xqx3

TODAY: Novavax partner, SK bioscience, has submitted a Post Approval Change Application to the Korean Ministry of Food and Drug Safety (식품의약품안전처) for our #COVID19Vaccine as a booster for adults aged 18 and older. Learn more: novav.ax/3elUvMm

Thank you to everyone who attended 'The Shift to Endemic: Living Alongside COVID-19' featuring our very own Chief Commercial Officer, John Trizzino, at MD Tech Council Bio Innovation Conference! #MDLSBioInnovation

Novavax je jednou z nejvýznamnějších 🇺🇸 investic v oblasti zdravotnictví v 🇨🇿 a hraje důležitou roli ve zmírnění dopadů pandemie. Bylo mi ctí navštívit výrobní závod Novavax, kde vyrábí klíčovou složku své vakcíny proti COVID-19. ~ CJA #CDAAgor

Novavax today announced that an initial one million doses of our #COVID19vaccine are now available for use in the United Kingdom. Those eligible for the vaccine will be identified by their healthcare providers. Learn more: novav.ax/3DYoR1Y